Drug Resistance in Colorectal Cancer: From Mechanism to Clinic

SIMPLE SUMMARY: Chemotherapy, radiotherapy and molecularly targeted therapy could improve the prognosis of colorectal cancer (CRC) patients. Recently, immunotherapy, especially immune checkpoint inhibitors, has significantly improved the prognosis of some patients. However, drug resistance significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qianyu, Shen, Xiaofei, Chen, Gang, Du, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221177/
https://www.ncbi.nlm.nih.gov/pubmed/35740594
http://dx.doi.org/10.3390/cancers14122928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221177/
https://www.ncbi.nlm.nih.gov/pubmed/35740594
http://dx.doi.org/10.3390/cancers14122928

Ejemplares similares